论文部分内容阅读
目的:探讨联合雾化吸入疗法在慢性阻塞性疾病急性加重期治疗中的临床效果;方法:从我院2012年3月至2014年3月收治的慢性阻塞性疾病急性加重期患者中选取82例为观察对象,随机分为观察组与对照组,每组41例,对照组行常规治疗,观察组行布地奈德与异丙托溴铵联合雾化吸入治疗,观察两组患者动脉气血及肺功能情况;结果:观察组动脉气血与肺功能恢复情况均明显优于对照组,差异具有统计学意义(P<0.05);结论:在慢性阻塞性疾病急性加重期治疗中,采用联合雾化吸入疗法,能有效缓解症状,改善肺部功能,值得临床推广运用。
Objective: To investigate the clinical effect of combined inhalation therapy in the treatment of chronic exacerbation of chronic obstructive disease.Methods: 82 cases of acute exacerbation of chronic obstructive disease admitted to our hospital from March 2012 to March 2014 were selected The patients were randomly divided into observation group and control group, 41 cases in each group. The control group received routine treatment. Budesonide and ipratropium bromide group were treated by atomization inhalation. The arterial blood gas, (P <0.05) .Conclusion: In the treatment of acute exacerbation of chronic obstructive disease, the combined use of fog Inhalation therapy, can effectively relieve symptoms, improve lung function, it is worth clinical promotion and use.